FIELD: medicine.
SUBSTANCE: pharmaceutical composition for prevention or treatment of inflammatory intestinal diseases (IID), which contains 7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triasolo[4,5-c][1]-benzazepine, or its prodrug, preferably 2-(1-isopropoxycarbonyloxy-2-methypropyl)-7,8-dimethoxy-4(5H), 10-dioxi-2H-1,2,3-triasolo[4,5-c] [1]benzazepine, or its pharmaceutically acceptable salt; respective method of prevention or IID treatment and application of said compounds for manufacturing preventive or therapeutic substance against IID. Demonstrated is efficiency of claimed pharmaceutical composition, more powerful than sulfasalazine and prednisolon with respect to said purpose, in combination with high safety. Shown are few side effects of compounds, absence of inhibition of IL-2, IL-4, IL-5, IFN-gamma, absence of weight gain restraint resulting from treatment.
EFFECT: pharmaceutical composition in accordance with claimed invention can demonstrate powerful preventive and therapeutic action, even in case of severe form of disease with resistance to conventional therapeutic agents.
28 cl, 3 dwg, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC MEDICATION FOR INFLAMMATORY INTESTINAL DISEASES WHICH CONTAINS DERIVATIVE OF 2-AMINO-1,3-PROPANDIOL AS ACTIVE INGREDIENT, OR METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2007 |
|
RU2428976C2 |
PYRIMIDINE INDOLE COMPOUNDS | 2010 |
|
RU2552999C2 |
METHOD OF OBTAINING HIGHLY PURIFIED ASIATICOSIDE COMPOSITION FROM Centella asiatica AND METHOD OF APPLICATION THEREOF | 2010 |
|
RU2565410C2 |
KOBITOLIMOD FOR USE IN TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2018 |
|
RU2766356C2 |
CONNECTIONS OF SUBSTITUTED TRIAZOLBRONIC ACID | 2013 |
|
RU2625801C2 |
NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | 2011 |
|
RU2585763C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASES (IID) | 2010 |
|
RU2561040C2 |
MEDICINAL COMPOSITIONS | 1997 |
|
RU2197226C2 |
OESTROGEN RECEPTOR MODULATORS | 2005 |
|
RU2394820C2 |
MEDICAL APPLICATION OF ARTEMISININ DERIVATIVES FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE | 2018 |
|
RU2746707C1 |
Authors
Dates
2012-12-20—Published
2008-12-17—Filed